Amneal Pharmaceuticals Quote - AMRX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

8.3013

Bid

8.40

Offer

8.68

Volume

1,499,840

8.37 Day's Range 9.01

5.01 52 Week Range 9.475

Market Cap

2.57B

Previous Close

9.00

Open

9.00

Last Trade

8.43

Last Trade Time

Financial Volume

US$ 12,918,739

VWAP

8.6134

Average Volume (3m)

1,129,003

Shares Outstanding

309,542,608

Dividend Yield

PE Ratio

-21.64

Earnings Per Share (EPS)

-0.27

Revenue

2.41B

Net Profit

-83.99M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.amneal.com

Headquarters

Wilmington, Delaware, USA

Founded

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMRX. The last closing price for Amneal Pharmaceuticals was US$9. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of US$ 5.01 to US$ 9.475.

Amneal Pharmaceuticals currently has 309,542,608 shares in issue. The market capitalisation of Amneal Pharmaceuticals is US$2.79 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.64.

Overall Flow

Bearish

Net Premium

-35k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases

Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera’s portfolio of novel injectable and oral development programs...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1513	1.85644171779	8.15	9.475	7.52	1565515	9.04763758	CS
4	-0.1587	-1.87588652482	8.46	9.475	7.52	1097564	8.6803261	CS
12	0.1913	2.3588162762	8.11	9.475	7.52	1129003	8.59494558	CS
26	1.4513	21.1868613139	6.85	9.475	6.29	1246685	7.7325316	CS
52	2.4213	41.1785714286	5.88	9.475	5.01	1373634	6.80117871	CS
156	2.4213	41.1785714286	5.88	9.475	5.01	1373634	6.80117871	CS
260	2.4213	41.1785714286	5.88	9.475	5.01	1373634	6.80117871	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.23M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	51.98M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.15M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.3M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.13M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.15B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	377.69M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	244.07M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	164.49M
STISolidion Technology Inc	US$ 0.44 (25.71%)	139.46M